The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Procalcitonin Market Research Report 2025
Synopsis
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
The global Procalcitonin market was valued at US$ 72 million in 2023 and is anticipated to reach US$ 118.6 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
This report aims to provide a comprehensive presentation of the global market for Procalcitonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin.
Report Scope
The Procalcitonin market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procalcitonin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Segment by Type
Procalcitonin Antigen
Procalcitonin Antibody
Segment by Application
Medical Industry
Scientific Research
Veterinarian
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Procalcitonin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
The global Procalcitonin market was valued at US$ 72 million in 2023 and is anticipated to reach US$ 118.6 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
This report aims to provide a comprehensive presentation of the global market for Procalcitonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin.
Report Scope
The Procalcitonin market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Procalcitonin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Segment by Type
Procalcitonin Antigen
Procalcitonin Antibody
Segment by Application
Medical Industry
Scientific Research
Veterinarian
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Procalcitonin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Procalcitonin Market Overview
1.1 Product Overview and Scope of Procalcitonin
1.2 Procalcitonin Segment by Type
1.2.1 Global Procalcitonin Market Value Comparison by Type (2024-2030)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin Segment by Application
1.3.1 Global Procalcitonin Market Value by Application: (2024-2030)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Global Procalcitonin Market Size Estimates and Forecasts
1.4.1 Global Procalcitonin Revenue 2019-2030
1.4.2 Global Procalcitonin Sales 2019-2030
1.4.3 Global Procalcitonin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Procalcitonin Market Competition by Manufacturers
2.1 Global Procalcitonin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Procalcitonin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Procalcitonin Average Price by Manufacturers (2019-2024)
2.4 Global Procalcitonin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Procalcitonin, Product Type & Application
2.7 Procalcitonin Market Competitive Situation and Trends
2.7.1 Procalcitonin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Procalcitonin Players Market Share by Revenue
2.7.3 Global Procalcitonin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Procalcitonin Retrospective Market Scenario by Region
3.1 Global Procalcitonin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Procalcitonin Global Procalcitonin Sales by Region: 2019-2030
3.2.1 Global Procalcitonin Sales by Region: 2019-2024
3.2.2 Global Procalcitonin Sales by Region: 2025-2030
3.3 Global Procalcitonin Global Procalcitonin Revenue by Region: 2019-2030
3.3.1 Global Procalcitonin Revenue by Region: 2019-2024
3.3.2 Global Procalcitonin Revenue by Region: 2025-2030
3.4 North America Procalcitonin Market Facts & Figures by Country
3.4.1 North America Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Procalcitonin Sales by Country (2019-2030)
3.4.3 North America Procalcitonin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Procalcitonin Market Facts & Figures by Country
3.5.1 Europe Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Procalcitonin Sales by Country (2019-2030)
3.5.3 Europe Procalcitonin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Procalcitonin Market Facts & Figures by Country
3.6.1 Asia Pacific Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Procalcitonin Sales by Country (2019-2030)
3.6.3 Asia Pacific Procalcitonin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Procalcitonin Market Facts & Figures by Country
3.7.1 Latin America Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Procalcitonin Sales by Country (2019-2030)
3.7.3 Latin America Procalcitonin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Procalcitonin Market Facts & Figures by Country
3.8.1 Middle East and Africa Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Procalcitonin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Procalcitonin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Procalcitonin Sales by Type (2019-2030)
4.1.1 Global Procalcitonin Sales by Type (2019-2024)
4.1.2 Global Procalcitonin Sales by Type (2025-2030)
4.1.3 Global Procalcitonin Sales Market Share by Type (2019-2030)
4.2 Global Procalcitonin Revenue by Type (2019-2030)
4.2.1 Global Procalcitonin Revenue by Type (2019-2024)
4.2.2 Global Procalcitonin Revenue by Type (2025-2030)
4.2.3 Global Procalcitonin Revenue Market Share by Type (2019-2030)
4.3 Global Procalcitonin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Procalcitonin Sales by Application (2019-2030)
5.1.1 Global Procalcitonin Sales by Application (2019-2024)
5.1.2 Global Procalcitonin Sales by Application (2025-2030)
5.1.3 Global Procalcitonin Sales Market Share by Application (2019-2030)
5.2 Global Procalcitonin Revenue by Application (2019-2030)
5.2.1 Global Procalcitonin Revenue by Application (2019-2024)
5.2.2 Global Procalcitonin Revenue by Application (2025-2030)
5.2.3 Global Procalcitonin Revenue Market Share by Application (2019-2030)
5.3 Global Procalcitonin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Procalcitonin Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Corporation Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Diagnostics Procalcitonin Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 bioMerieux
6.3.1 bioMerieux Corporation Information
6.3.2 bioMerieux Description and Business Overview
6.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 bioMerieux Procalcitonin Product Portfolio
6.3.5 bioMerieux Recent Developments/Updates
6.4 HyTest
6.4.1 HyTest Corporation Information
6.4.2 HyTest Description and Business Overview
6.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HyTest Procalcitonin Product Portfolio
6.4.5 HyTest Recent Developments/Updates
6.5 BBI Solutions
6.5.1 BBI Solutions Corporation Information
6.5.2 BBI Solutions Description and Business Overview
6.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BBI Solutions Procalcitonin Product Portfolio
6.5.5 BBI Solutions Recent Developments/Updates
6.6 ProSpec
6.6.1 ProSpec Corporation Information
6.6.2 ProSpec Description and Business Overview
6.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ProSpec Procalcitonin Product Portfolio
6.6.5 ProSpec Recent Developments/Updates
6.7 Wondfo
6.6.1 Wondfo Corporation Information
6.6.2 Wondfo Description and Business Overview
6.6.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wondfo Procalcitonin Product Portfolio
6.7.5 Wondfo Recent Developments/Updates
6.8 Ningbo Medicalsystem Biotechnology
6.8.1 Ningbo Medicalsystem Biotechnology Corporation Information
6.8.2 Ningbo Medicalsystem Biotechnology Description and Business Overview
6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
6.9 Wuhan Easy Diagnosis Biomedicine
6.9.1 Wuhan Easy Diagnosis Biomedicine Corporation Information
6.9.2 Wuhan Easy Diagnosis Biomedicine Description and Business Overview
6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
6.10 Snibe
6.10.1 Snibe Corporation Information
6.10.2 Snibe Description and Business Overview
6.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Snibe Procalcitonin Product Portfolio
6.10.5 Snibe Recent Developments/Updates
6.11 Vazyme Biotech
6.11.1 Vazyme Biotech Corporation Information
6.11.2 Vazyme Biotech Procalcitonin Description and Business Overview
6.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vazyme Biotech Procalcitonin Product Portfolio
6.11.5 Vazyme Biotech Recent Developments/Updates
6.12 Getein Biotech
6.12.1 Getein Biotech Corporation Information
6.12.2 Getein Biotech Procalcitonin Description and Business Overview
6.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Getein Biotech Procalcitonin Product Portfolio
6.12.5 Getein Biotech Recent Developments/Updates
6.13 Hotgen Biotech
6.13.1 Hotgen Biotech Corporation Information
6.13.2 Hotgen Biotech Procalcitonin Description and Business Overview
6.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hotgen Biotech Procalcitonin Product Portfolio
6.13.5 Hotgen Biotech Recent Developments/Updates
6.14 Lumigenex
6.14.1 Lumigenex Corporation Information
6.14.2 Lumigenex Procalcitonin Description and Business Overview
6.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lumigenex Procalcitonin Product Portfolio
6.14.5 Lumigenex Recent Developments/Updates
6.15 Nanjing Norman Biological Technology
6.15.1 Nanjing Norman Biological Technology Corporation Information
6.15.2 Nanjing Norman Biological Technology Procalcitonin Description and Business Overview
6.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
6.15.5 Nanjing Norman Biological Technology Recent Developments/Updates
6.16 Kitgen
6.16.1 Kitgen Corporation Information
6.16.2 Kitgen Procalcitonin Description and Business Overview
6.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kitgen Procalcitonin Product Portfolio
6.16.5 Kitgen Recent Developments/Updates
6.17 Beijing KeyGen
6.17.1 Beijing KeyGen Corporation Information
6.17.2 Beijing KeyGen Procalcitonin Description and Business Overview
6.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Beijing KeyGen Procalcitonin Product Portfolio
6.17.5 Beijing KeyGen Recent Developments/Updates
6.18 Beijing Apis
6.18.1 Beijing Apis Corporation Information
6.18.2 Beijing Apis Procalcitonin Description and Business Overview
6.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beijing Apis Procalcitonin Product Portfolio
6.18.5 Beijing Apis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Procalcitonin Industry Chain Analysis
7.2 Procalcitonin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Procalcitonin Production Mode & Process
7.4 Procalcitonin Sales and Marketing
7.4.1 Procalcitonin Sales Channels
7.4.2 Procalcitonin Distributors
7.5 Procalcitonin Customers
8 Procalcitonin Market Dynamics
8.1 Procalcitonin Industry Trends
8.2 Procalcitonin Market Drivers
8.3 Procalcitonin Market Challenges
8.4 Procalcitonin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
